News from isofol medical ab (publ) A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 02, 2020, 07:25 ET Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada

Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) is pleased to announce today a definitive license agreement...


Nov 02, 2020, 07:17 ET Invitation to a conference call and webcast by Isofol in connection with the entered license agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada

Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced a definitive licensing agreement with...


Sep 30, 2020, 02:46 ET 55 % Overall Response Rate on the safety extension cohorts of the ISO-CC-005 Phase I/IIa study

Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today provided an update on the extension study portion of the...


Aug 13, 2020, 02:51 ET Invitation to a conference call and webcast by Isofol in connection with the entered license agreement with Solasia

Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced that it entered into a license agreement...


Aug 13, 2020, 02:44 ET Isofol enters licensing agreement with Solasia to develop and commercialize arfolitixorin in Japan

Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) today announced that it entered into a license agreement with ...


Aug 04, 2020, 06:52 ET Isofol's CEO Ulf Jungnelius has subscribed for all warrants

Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL), today announced that the CEO Ulf Jungnelius has chosen to make full use...


Jul 10, 2020, 09:25 ET AGENT Study Update With Regards to COVID-19

Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL), informs that the outbreak of COVID-19 has affected the general situation ...